Thalidomide maintenance therapy maturates the T cell compartment and compromises antigen-specific antitumor immunity in patients with multiple myeloma.

I. Herth,M. Witzens‐Harig,P. Beckhove,D. Hose,T. Meissner,Brigitte Neuber,Melanie Engelhardt,J. Haas,K. Neben,A. Ho,B. Klein,H. Goldschmidt,M. Hundemer
DOI: https://doi.org/10.1016/j.exphem.2012.10.018
IF: 3.249
2013-03-01
Experimental Hematology
Abstract:
What problem does this paper attempt to address?